NCT00166621View on ClinicalTrials.gov

Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

August 31, 2005

Conditions
Autism
Interventions
DRUG

Buspirone

Trial Locations (1)

48201

PET Center/Children's Hospital of Michigan, Detroit

All Listed Sponsors
lead

Chugani, Diane C.

INDIV

NCT00166621 - Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy | Biotech Hunter | Biotech Hunter